JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubocovich, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubocovich, M. L.

Luzindole (N-0774): a novel melatonin receptor antagonist

ML Dubocovich

Department of Pharmacology, Northwestern University Medical School, Chicago, Illinois.

The pharmacological potencies of 2-substituted N-acetyltryptamines were determined on the presynaptic melatonin receptor site of rabbit retina labeled in vitro with [3H]dopamine. Calcium-dependent release of [3H]dopamine was elicited by electrical stimulation at 3 Hz for 2 min (20 mA, 2 msec). Melatonin (5-OCH3-N-acetyltryptamine) and 6- chloromelatonin were equipotent in inhibiting the calcium-dependent release of [3H]dopamine (IC50 = 40 pM). 2-Substituted N- acetyltryptamines with a methyl (i.e., 6,7-dichloro-2-methylmelatonin, IC50 = 10 pM) or iodine (i.e., 2-iodomelatonin, IC50 = 5 pM) group were more potent than melatonin in inhibiting [3H]dopamine release. I report here the pharmacological properties of the novel N-acetyltryptamine, 2- benzyl-N-acetyltryptamine (N-0774, luzindole) on the presynaptic melatonin receptor of rabbit retina. Luzindole (0.1-10 microM) did not affect the spontaneous outflow of radioactivity or the stimulation- evoked release of [3H]dopamine when added alone. However, luzindole (0.1-10 microM) shifted the concentration effect curve for melatonin to the right in a parallel fashion. The pA2 extrapolated from the Schild plot (slope, 0.91) was 7.7, with a KB = 20 nM. The dissociation constants for luzindole (KB), determined in the presence of 6,7- dichloro-2-methylmelatonin (10 pM-1 nM) or 6-chloromelatonin (10 pM-100 nM) were 16 and 40 nM, respectively. These data suggest that luzindole and the various melatonin agonists are competing for the same presynaptic melatonin receptor site in the rabbit retina.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 246, Issue 3, pp. 902-910, 09/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
ScienceHome page
O. Rawashdeh, N. H. de Borsetti, G. Roman, and G. M. Cahill
Melatonin Suppresses Nighttime Memory Formation in Zebrafish
Science, November 16, 2007; 318(5853): 1144 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. Steffens, X.-B. Zhou, U. Sausbier, C. Sailer, K. Motejlek, P. Ruth, J. Olcese, M. Korth, and T. Wieland
Melatonin Receptor Signaling in Pregnant and Nonpregnant Rat Uterine Myocytes as Probed by Large Conductance Ca2+-Activated K+ Channel Activity
Mol. Endocrinol., October 1, 2003; 17(10): 2103 - 2115.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Roy and D. D. Belsham
Melatonin Receptor Activation Regulates GnRH Gene Expression and Secretion in GT1-7 GnRH Neurons. SIGNAL TRANSDUCTION MECHANISMS
J. Biol. Chem., January 4, 2002; 277(1): 251 - 258.
[Abstract] [Full Text]


Home page
Sci SignalHome page
M. I. Masana and M. L. Dubocovich
Melatonin Receptor Signaling: Finding the Path Through the Dark
Sci. Signal., November 6, 2001; 2001(107): pe39 - pe39.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. L. Drazen, D. Bilu, S. D. Bilbo, and R. J. Nelson
Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1476 - R1482.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. L. Dubocovich, K. Yun, W. M. Al-ghoul, S. Benloucif, and M. I. Masana
Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms
FASEB J, September 1, 1998; 12(12): 1211 - 1220.
[Abstract] [Full Text]


Home page
FASEB J.Home page
B. Ancona, L. Facci, D. Franceschini, and P. Giusti
Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway
FASEB J, June 1, 1998; 12(9): 725 - 731.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
I. J. M. Beresford, C. Browning, S. J. Starkey, J. Brown, S. M. Foord, J. Coughlan, P. C. North, M. L. Dubocovich, and R. M. Hagan
GR196429: A Nonindolic Agonist at High-Affinity Melatonin Receptors
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1239 - 1245.
[Abstract] [Full Text]


Home page
J Biol RhythmsHome page
C. E. Reme, A. Wirz-Justice, and M. Terman
The Visual Input Stage of the Mammalian Circadian Pacemaking System: I. Is There a Clock in the Mammalian Eye?
J Biol Rhythms, March 1, 1991; 6(1): 5 - 29.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics.